Opko Health (OPK) Operating Leases (2019 - 2026)

Opko Health has reported Operating Leases for 8 years, with the latest figure at $35.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 26.12% year-over-year to $35.6 million; the trailing twelve-month figure through Mar 2026 stood at $35.6 million (down 26.12% YoY), and the FY2025 full-year result was $36.8 million, down 24.64% from the prior year.
• Operating Leases for Q1 2026 stood at $35.6 million, down from $36.8 million in the prior quarter.
• The five-year high for Operating Leases was $64.8 million in Q3 2024, with the low at $26.5 million in Q1 2023.
• Historically, Operating Leases has averaged $42.7 million across 5 years, with a median of $37.3 million in 2025.
• The largest YoY upside for Operating Leases was 93.61% in 2023 against a maximum downside of 51.18% in 2023.
• Opko Health's Operating Leases stood at $28.0 million in 2022, then soared by 93.61% to $54.1 million in 2023, then declined by 9.77% to $48.8 million in 2024, then retreated by 24.64% to $36.8 million in 2025, then declined by 3.2% to $35.6 million in 2026.
• The last three Operating Leases figures came in at $35.6 million (Q1 2026), $36.8 million (Q4 2025), and $36.3 million (Q3 2025), per Business Quant data.